Opko Health Inc
* Transition Therapeutics shareholders approve acquisition by OPKO Health
* Shareholders of transition therapeutics holding approximately 93% of outstanding common shares, voted to approve agreement
* Court hearing for final order is scheduled to take place on August 29, 2016, and acquisition is expected to close on September 1, 2016, Source text for Eikon: Further company coverage:
Recent Articles on M&A
Source: Reuters.com